Allstocks.com's Bulletin Board Post New Topic  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » .11 and Up! » SGMO---NEWS

 - UBBFriend: Email this page to someone!    
Author Topic: SGMO---NEWS
Rollercoast
Member


Rate Member
Icon 1 posted      Profile for Rollercoast     Send New Private Message       Edit/Delete Post   Reply With Quote 
SGMO -- Sangamo BioSciences, Inc.
Com (1 Cent)
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:

Sigma-Aldrich Corporation enters into research and development collaboration with Sangamo BioSciences

Jul 11, 2007 (M2 EQUITYBITES via COMTEX) -- Sigma-Aldrich Corporation (Nasdaq: SIAL), a life science and high technology company, declared on 10 July that it has entered into a significant alliance with Sangamo BioSciences Inc (Nasdaq: SGMO), a researcher and developer of zinc finger DNA-binding proteins (ZFPs), focussing on the development of high value laboratory research reagents based upon the Sangamo's ZFP technology.
The collaboration will combine Sigma's global marketing capabilities and significant reputation as a provider of products and kits for scientific research with Sangamo's substantial expertise in the field of ZFPs.

ZFPs are the dominant class of naturally occurring proteins known as transcription factors and are found in the nucleus of every cell and are amenable to engineering and precise targeting to a particular gene or genes of interest.

Scientists at Sigma-Aldrich and Sangamo will use ZFNs like precision 'surgical instruments' to modify genes in cells and to develop and market ZFP products for broad use in numerous laboratory research reagent applications.

The license agreement allows Sigma-Aldrich to make initial payments of USD13.5m to Sangamo, consisting of an upfront license payment and the purchase of 1,000,000 common shares of Sangamo at market price and has the right to sublicense the technology for research applications.

Additionally, Sangamo will receive additional committed funding including fees and minimum annual payments and is eligible to receive payments of up to USD22m if certain development and commercial milestones are achieved. It will also receive royalties on any product sales or services developed using the ZFP technology and 50% of any sublicensing revenues in the first two years and 25% of any sublicensing revenues thereafter.

--------------------
Pennies are for trading.

Posts: 82 | From: dixon ca us | Registered: Jun 2004  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2013 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share